Friday, January 31, 2025
HomeIndustriesBiotechnology

Biotechnology

Rejuveron Increases to Near-majority Stake in Endogena Through Funding $20m to Progress Treatments for Degenerative Diseases of the Eye

Rejuveron Life Sciences AG, a Zürich-based biotechnology company developing technologies for healthy aging, announced that it has strengthened its support to a near-majority holding...

Biocytogen/Eucure Biopharma Announce the Completion of First Patient Dosing for Phase II Clinical Trial of YH003 in Australia

Eucure Biopharma, a wholly owned subsidiary of Biocytogen, announced the first patient dosing for a phase II clinical trial of YH003 (anti-CD40 monoclonal antibody,...

PsiQuantum and QunaSys Partner to Advance Industrial Chemistry and Materials Science through Quantum Computing

PsiQuantum and QunaSys, Inc. announced a joint research project to assess the power of fault-tolerant quantum computing for industrial chemistry calculations aimed at accelerating...

GenScript ProBio Opens China’s Largest Commercial GMP Plasmid Manufacturing Facility

GenScript ProBio announced today the opening of China's largest commercial GMP plasmid manufacturing facility during a ceremony at the site in Zhenjiang, Jiangsu Province....

The News This Week: Read Magazine’s Weekly News Roundup featuring Dassault, Bombardier, Volkswagen, Siemens, and McCain

Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast paced world, breaking down information helps readers grasp...
0FansLike
0FollowersFollow
spot_img

Hot Topics